Last reviewed · How we verify

NCT02751684: EUROpE-RSI

EUROpE-RSI (EURopean Online Evaluation RSI Study)

Completed Last updated 4 April 2019
What this trial tests

trial in Rapid Sequence Induction in 1,500 participants. Completed in 31 May 2017.

Timeline
1 March 2017
Primary endpoint
31 May 2017
31 May 2017

Quick facts

Lead sponsorUniversitätsklinikum Köln
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,500
Start date1 March 2017
Primary completion31 May 2017
Estimated completion31 May 2017
Sites1 location across Germany

Conditions studied

Sponsor

Universitätsklinikum Köln — full company profile →

Who can join

Adults 25 to 70, any sex, with Rapid Sequence Induction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators want to identify and show differences in standards and procedures of in-hospital rapid sequence induction by collecting data with an online survey for anaesthetist in Europe.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Rapid Sequence Induction

Currently open trials in the same condition.

Other Universitätsklinikum Köln trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02751684.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing